TBPH: Theravance Corp Forvard P/S multiplikatori

Theravance (TBPH) korporativ emblemasi va logotipi

Respirator kasalliklar davolash bo'yicha barqaror litsenziyalash royaltilari Theravance Biopharma (TBPH) uchun joriy moliyaviy asosni ta'minlaydi. Kompaniyaning prognoz qilingan P/S ko'rsatkichi bozor shovqinlarini yumshatishga yordam beradi, 5.00 esa ushbu metrikaning joriy qiymatini ko'rsatadi. Shu bilan birga, daromadlar GI dori vositalari sinovlarining muvaffaqiyati va xarajatlarni optimallashtirishga bog'liq. R&D xatarlari shaxsiy ishlanmalar va global royaltilarni birlashtirgan gibrid model orqali yumshatiladi.

Theravance Biopharma, Inc. - TBPH Bozor kapitallashuvining kelajakdagi daromadga nisbati (davr: 04.07.2022 - 10.10.2026)

Theravance Biopharma, Inc. (TBPH) kompaniyasi koʻrsatkichlari kesimi va tahlili

Kompaniyaning jamlanma tahliliyoti:Theravance Biopharma Inc TBPH
theravance.com tovar namunasi

Oldingi P/S koeffitsiyenti aksiyaning joriy narxi va keyingi yil uchun prognoz qilingan savdo hajmi o'rtasidagi bog'liqlikni aks ettiradi. Ushbu metrika investorlarga rasmiy moliyaviy hisobotlar e'lon qilinishidan oldin biznes kapitalizatsiyasiga nisbatan bozor kutganlarini baholash imkonini beradi. Kutilayotgan daromad multiplikatorini tahlil qilish orqali aktivning haddan tashqari sotib olinganlik darajasini yoki uning o'sish potentsialini aniqlash mumkin. Theravance Biopharma (TBPH) uchun ushbu ko'rsatkich juda muhimdir, chunki u respirator kasalliklar terapiyasidagi innovatsion inhalatsiya texnologiyalarining tijorat muvaffaqiyatini aks ettiradi.

Theravance Biopharma raqobatchilari

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning prognoz qilingan daromadga nisbati|SCPH (scpharmaceuticals.com) - Forvard P/S multiplikatori|TECX: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Sotuvga nisbatan forvard narx BHST|Invizyne Technologies - Forvard P/S multiplikatori|oramed.com (ORMP) - Forvard narx/daromad multiplikatori|ENTX (enterabio.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HYFT|ABVC (ABVC BioPharma, Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori cumberlandpharma.com|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP